DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors
- 30 September 1995
- journal article
- Published by Elsevier in Mutation Research/DNA Repair
- Vol. 337 (2) , 135-145
- https://doi.org/10.1016/0921-8777(95)00019-g
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mutagenicity and carcinogenicity of topoisomerase-interactive agentsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- DNA topoisomerasesCurrent Opinion in Cell Biology, 1992
- Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitroMutagenesis, 1990
- Induction of chromosomal aberrations and SCE by camptothecin, and inhibitor of mammalian topoisomerase IMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
- Topoisomerase I Interaction with SV4O DNA in the presence and absence of camptothecinNucleic Acids Research, 1988
- Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavageJournal of Molecular Biology, 1988
- Association of Crossover Points with Topoisomerase I Cleavage Sites: A Model for Nonhomologous RecombinationScience, 1985
- A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in tetrahymena R-chromatinCell, 1985
- Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairingJournal of Molecular Biology, 1984
- Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNANucleic Acids Research, 1984